News

Mahindra & Mahindra shares surged following Nomura's Buy rating and a Rs 4,335 price target, driven by the launch of the feature-rich XEV 9S at a disruptive price. The brokerage anticipates strong SUV growth and sees the new vehicle as a catalyst for Mahindra's electric era, with bookings opening in January 2026.

Motilal Oswal has identified five stocks with significant upside potential, including Tata Steel, Coforge, Max Financial Services, TVS Motor Company, and Bharat Electronics. These recommendations come as the Nifty 50 index reaches an all-time high, driven by strong domestic fundamentals and policy support.

Gold prices opened higher above Rs 1.28 lakh, nearing two-week highs amid Fed rate cut optimism and a softer dollar, while silver also gained nearly 1%. Analysts expect volatility ahead of key global data, with gold and silver seen trading within defined support and resistance ranges on MCX.

Foreign investors are heavily investing in India's telecom sector, pouring 43,000 crore into it. This surge is driven by expected tariff hikes, rising average revenue per user (ARPU), and the upcoming Jio IPO. Analysts are optimistic about a multi-year monetization cycle, with major brokerages upgrading their outlook and projecting strong earnings growth for companies like Airtel and Jio.

Vidya Wires is launching its Rs 300-crore IPO on December 3 with a price band of Rs 4852. The issue includes fresh shares and an OFS, valuing the firm at a discount to industry peers. With strong FY25 revenues and solid profitability, the IPO offers attractive sector-linked growth potential.

Indian stocks opened slightly higher on Friday, with both the Sensex and Nifty hovering near their all-time highs. Investors are anticipating interest-rate cuts in the U.S. and India, while also looking forward to resilient quarterly growth data driven by strong domestic demand.

A 5-year swing high marks the highest price a stock has reached in the past five years and often acts as a significant resistance level.

Emcure Pharmaceuticals' shares could see action following a Goods and Services Tax search at its Mumbai offices. The inspection concluded this week. The company recently reported a robust rise in revenue and profit after tax. Domestic and international businesses both showed strong performance.

Indian government bonds are poised for a flat to slightly lower opening as traders anticipate a significant debt auction today, followed by crucial economic growth figures. The benchmark 10-year yield is expected to trade within a narrow band.

Zydus Lifesciences is set to be in focus after it received tentative approval from the United States Food and Drug Administration for Empagliflozin and Linagliptin combination tablets for type 2 diabetes, alongside final approval for a blood pressure treatment drug. The company also entered into a licensing and commercialisation pact with RK Pharma for a supportive oncology product in the US. Shares ended marginally lower on Thursday as investors assessed the latest regulatory developments.

On November 27, four stocks in the Nifty500 that gained over 3% appeared in the RSI Trending Up scan, according to data from StockEdge.

Futures open interest surged over 10% in five NSE F&O stocks, signalling fresh positions and heightened market participation.

Indian markets hit fresh all-time highs as improving earnings, GST cuts, and easing macro pressures boost investor confidence. Quantum Advisors Nilesh Shetty says the worst of earnings downgrades is over, with banks, IT and insurance offering strong value. Industrial and FMCG stocks may lag, while an IndiaUS tariff deal could trigger the next big market catalyst.

In the Nifty500 pack, 10 stocks saw their closing prices fall below their 200-day moving average (200 DMA) on November 27, according to technical scan data from StockEdge.

We have collated a list of stocks recommendations from top brokerage firms from ETNow and other sources.

Aequs has set its IPO price band at Rs 118124, valuing the Rs 921.72 crore issue comprising a fresh sale and OFS. Despite FY25 losses and negative EPS, the company raised Rs 144 crore in a strong pre-IPO placement. Known for aerospace and consumer precision engineering, Aequs will list on December 10, with allotment on December 8.

Jefferies initiated coverage on Lenskart with a 'Buy' rating, setting a Rs 500 price target, suggesting a 23% upside. The brokerage highlights Lenskart's leadership in India's under-penetrated eyewear market, driven by its tech-enabled, omni-channel model and strong store economics. Growth is expected from network expansion and international operations.

Exato Technologies 37.45 crore SME IPO opened on Friday with strong investor demand, reflected in a grey market premium of around 83%. The issue, priced at 133140 per share, closes on December 2. Retail investors must apply for a minimum of 2,000 shares (2.8 lakh), while HNIs must bid for at least three lots (4.2 lakh+). High participation is expected following strong pre-opening demand.

Logiciel Solutions 39.90 crore SME IPO opened on Friday with steady investor interest, reflected in a grey market premium of around 21%. The issue, priced at 183193 per share, includes a 32.70 crore fresh issue and a 7.20 crore offer for sale. Retail investors must apply for at least 1,200 shares (2.31 lakh at the upper band).

Purple Wave Infocoms 31.45 crore SME IPO opened on Friday with no grey-market premium, indicating a neutral debut. The issue, priced at 120126 per share, is a fully fresh offer of 24.96 lakh shares and closes on December 2. Retail investors must bid for at least 2,000 shares, costing 2.52 lakh at the upper band. Allotment is due on December 3, with listing on December 5 on the BSE SME platform.

Thyrocare Technologies will trade ex-bonus today for its 2:1 bonus share issue, under which investors will receive two additional shares for every one held. The record date for determining eligible shareholders is November 28.